Bernard Klein

1.7k total citations
32 papers, 1.4k citations indexed

About

Bernard Klein is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Bernard Klein has authored 32 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 16 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Bernard Klein's work include Multiple Myeloma Research and Treatments (15 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Bernard Klein is often cited by papers focused on Multiple Myeloma Research and Treatments (15 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Bernard Klein collaborates with scholars based in France, Germany and United States. Bernard Klein's co-authors include Régis Bataille, John Wijdenes, Dirk Hose, J Brochier, Ren-Xiao Sun, Jean-Michel Doré, Natalio Vita, Patrick Laurent, Jacob Post and Claude Clément and has published in prestigious journals such as Nucleic Acids Research, Blood and CHEST Journal.

In The Last Decade

Bernard Klein

32 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard Klein France 17 645 635 462 370 143 32 1.4k
Marion Baudard France 18 541 0.8× 686 1.1× 369 0.8× 312 0.8× 141 1.0× 34 1.3k
Shinichi Mizuno Japan 16 1.0k 1.6× 698 1.1× 405 0.9× 316 0.9× 56 0.4× 46 1.8k
Masayoshi Minegishi Japan 19 417 0.6× 364 0.6× 270 0.6× 461 1.2× 132 0.9× 85 1.3k
DA Williams United States 16 575 0.9× 460 0.7× 444 1.0× 599 1.6× 105 0.7× 37 1.5k
S Neben United States 23 539 0.8× 738 1.2× 336 0.7× 706 1.9× 83 0.6× 41 1.6k
Sun Jin Choi United States 24 1.1k 1.7× 920 1.4× 1.4k 3.1× 287 0.8× 58 0.4× 30 2.2k
H Mizoguchi Japan 17 345 0.5× 353 0.6× 506 1.1× 602 1.6× 37 0.3× 54 1.4k
Serge Fichelson France 29 1.2k 1.9× 1.1k 1.8× 339 0.7× 482 1.3× 158 1.1× 65 2.5k
Nobuyoshi Arima Japan 23 428 0.7× 409 0.6× 421 0.9× 979 2.6× 38 0.3× 88 1.9k
Masahito Kawazu Japan 26 939 1.5× 319 0.5× 604 1.3× 312 0.8× 239 1.7× 61 2.0k

Countries citing papers authored by Bernard Klein

Since Specialization
Citations

This map shows the geographic impact of Bernard Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Klein more than expected).

Fields of papers citing papers by Bernard Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Klein. The network helps show where Bernard Klein may publish in the future.

Co-authorship network of co-authors of Bernard Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Klein. A scholar is included among the top collaborators of Bernard Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Klein. Bernard Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klein, Bernard, Jihane Basbous, Christophe Hirtz, et al.. (2017). RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma. Leukemia. 31(10). 2104–2113. 64 indexed citations
2.
Kassambara, Alboukadel, Michel Jourdan, Angélique Bruyer, et al.. (2017). Global miRNA expression analysis identifies novel key regulators of plasma cell differentiation and malignant plasma cell. Nucleic Acids Research. 45(10). 5639–5652. 32 indexed citations
3.
Jourdan, M, Maïlys Cren, Nicolas Robert, et al.. (2014). IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors. Leukemia. 28(8). 1647–1656. 110 indexed citations
4.
Schoenhals, Matthieu, Cecilia Frecha, Angélique Bruyer, et al.. (2012). Efficient transduction of healthy and malignant plasma cells by lentiviral vectors pseudotyped with measles virus glycoproteins. Leukemia. 26(7). 1663–1670. 10 indexed citations
5.
Moreaux, Jérôme, Bernard Klein, Régis Bataille, et al.. (2010). A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines. Haematologica. 96(4). 574–582. 124 indexed citations
6.
Hose, Dirk, Alboukadel Kassambara, Laure Vincent, et al.. (2010). Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation. Leukemia. 24(11). 1940–1950. 66 indexed citations
7.
Caers, Jo, Dirk Hose, Ine Kuipers, et al.. (2009). Thymosin  4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma. Haematologica. 95(1). 163–167. 22 indexed citations
8.
Noraz, Nelly, et al.. (2000). Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway. British Journal of Haematology. 111(2). 626–634. 118 indexed citations
9.
Sun, Ren-Xiao, Zhaoyang Lu, John Wijdenes, et al.. (1997). Large scale and clinical grade purification of syndecan-1+ malignant plasma cells. Journal of Immunological Methods. 205(1). 73–79. 24 indexed citations
10.
Wijdenes, John, Claude Clément, Jacob Post, et al.. (1996). A plasmocyte selective monoclonal antibody (B‐B4) recognizes syndecan‐1. British Journal of Haematology. 94(2). 318–323. 300 indexed citations
11.
Klein, Bernard, et al.. (1994). First isolation of a non-motile/tween 80 negative Yersinia ruckeri strain in Germany. Bulletin of the European Association of Fish Pathologists. 14(5). 165–166. 3 indexed citations
12.
Lu, Zhaoyang, et al.. (1994). A highly sensitive quantitative bioassay for human interleukin-11. Journal of Immunological Methods. 173(1). 19–26. 18 indexed citations
13.
Klein, Bernard, et al.. (1993). First isolations of Plesiomonas shigelloides from samples of cultured fish in Germany.. Bulletin of the European Association of Fish Pathologists. 13(2). 70–72. 5 indexed citations
14.
Klein, Bernard, John Wijdenes, XG Zhang, et al.. (1991). Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood. 78(5). 1198–1204. 38 indexed citations
15.
Pujol, Jean-Louis, et al.. (1991). Bacterial Ribosomal Immunostimulants Prime Alveolar Macrophages in Vivo to Produce Interleukin 1 in Vitro. CHEST Journal. 100(3). 644–648. 11 indexed citations
16.
Navarro, Séverine, Najet Debili, JP Le Couedic, et al.. (1991). Interleukin-6 and its receptor are expressed by human megakaryocytes: in vitro effects on proliferation and endoreplication. Blood. 77(3). 461–471. 7 indexed citations
17.
Commes, Thérèse, et al.. (1990). Human natural killer cells suppress the proliferation of B cells. Immunology Letters. 24(1). 57–61. 14 indexed citations
18.
Bataille, Régis, et al.. (1990). Constitutive production of interleukin‐6 and immunologic features in cardiac myxomas. Arthritis & Rheumatism. 33(3). 398–402. 134 indexed citations
19.
Vieu, J.F., et al.. (1989). Sensibilite aux antibiotiques de 580 souches hospitalieres de Pseudomonas aeruginosa isolees en Cote-d'Ivoire, Mauritanie, Niger, Senegal et Iles Canaries. Médecine et Maladies Infectieuses. 19(5). 319–321. 1 indexed citations
20.
Netter, R, et al.. (1975). Bacteriophage control of some virus vaccines and organ extracts for human use. Journal of Biological Standardization. 3(3). 311–319. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026